AMR

US pharmaceutical giant Eli Lilly announced a partnership with OpenAI to use the latter's generative AI technology to develop new antimicrobial drugs for the treatment of drug-resistant pathogens. Eli Lilly said that antimicrobial resistance (AMR) is currently one of the biggest threats to global public health and development. AMR affects countries in all regions and at all income levels, and poverty and inequality exacerbate the problem, especially for low- and middle-income countries. The misuse and overuse of antibiotics in humans, animals, and plants is the main driver of the development of drug-resistant pathogens, and the…